Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoid CB1 receptor agonist for severe chronic anorexia nervosa
2007-005631-29Phase 3Completed
- Sponsor
- Center for Spiseforstyrrelser
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of dronabinol in anorexia nervosa (AN), sponsored by Center for Spiseforstyrrelser. Primary endpoint: Weight gain on Marinol therapy. Started Mar 2008; status: completed.
02
Drugs
dronabinol
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on 2007-005631-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005631-29.